Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Arkhipkina (Kharkiv, Ukraine). Impact of cytokines on endothelium in COPD patients. 2221

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory cytokines of patients with peripheral arterial disease and COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002 Effects of RSV-infection on the cytokine-profile of T-lymphocytes from COPD patients Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – COPD management Year: 2017 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Cytokines status, endothelial function in patients with pulmonary diseases Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Effects of TNF α and interferon-γ on the expression of IL-8 and GROα in primary bronchial epithelial cells from healthy smokers and COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 458s Year: 2003